NPPB and acute kidney injury: Various methodological approaches have now been proposed to minimise the adverse effects of hypovolaemia and haemoconcentration on the risk of AKI, including monitoring NT-proBNP levels, markers of renal injury, creatinine elevation, and exclusively clinical features of congestion and response to diuretics [39,43,44].